{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:45:00Z","timestamp":1790797500859,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10574-7","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T12:02:32Z","timestamp":1705406552000},"page":"5439-5450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Current use and future perspectives of contrast-enhanced mammography (CEM): a survey by the European Society of Breast Imaging (EUSOBI)"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4243-888X","authenticated-orcid":false,"given":"Simone","family":"Schiaffino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Clauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Giannotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adele","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiemo J. A.","family":"van Nijnatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal A. T.","family":"Baltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B. I.","family":"Lobbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritse M.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Pinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Fuchsj\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud M.","family":"Pijnappel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European Society of Breast Imaging (EUSOBI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"10574_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.2019182947","volume":"292","author":"RM Mann","year":"2019","unstructured":"Mann RM, Cho N, Moy L (2019) Breast MRI: state of the art. Radiology 292:520\u2013536. https:\/\/doi.org\/10.1148\/radiol.2019182947","journal-title":"Radiology"},{"key":"10574_CR2","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1007\/s00330-022-08617-6","volume":"32","author":"RM Mann","year":"2022","unstructured":"Mann RM, Athanasiou A, Baltzer PAT et al (2022) Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol 32:4036\u20134045. https:\/\/doi.org\/10.1007\/s00330-022-08617-6","journal-title":"Eur Radiol"},{"key":"10574_CR3","doi-asserted-by":"publisher","unstructured":"Cozzi A, Schiaffino S, Sardanelli F (2019) The emerging role of contrast-enhanced mammography. Quant Imaging Med Surg 9:2012\u20132018. https:\/\/doi.org\/10.21037\/qims.2019.11.09.","DOI":"10.21037\/qims.2019.11.09"},{"key":"10574_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1148\/radiol.2021201948","volume":"299","author":"MS Jochelson","year":"2021","unstructured":"Jochelson MS, Lobbes MBI (2021) Contrast-enhanced mammography: state of the art. Radiology 299:36\u201348. https:\/\/doi.org\/10.1148\/radiol.2021201948","journal-title":"Radiology"},{"key":"10574_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1148\/radiol.211412","volume":"302","author":"A Cozzi","year":"2022","unstructured":"Cozzi A, Magni V, Zanardo M, Schiaffino S, Sardanelli F (2022) Contrast-enhanced mammography: a systematic review and meta-analysis of diagnostic performance. Radiology 302:568\u2013581. https:\/\/doi.org\/10.1148\/radiol.211412","journal-title":"Radiology"},{"key":"10574_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1148\/radiol.212530","volume":"305","author":"N P\u00f6tsch","year":"2022","unstructured":"P\u00f6tsch N, Vatteroni G, Clauser P, Helbich TH, Baltzer PAT (2022) Contrast-enhanced mammography versus contrast-enhanced breast mri: a systematic review and meta-analysis. Radiology 305:94\u2013103. https:\/\/doi.org\/10.1148\/radiol.212530","journal-title":"Radiology"},{"key":"10574_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.7150\/jca.79747","volume":"14","author":"LMFH Neeter","year":"2023","unstructured":"Neeter LMFH, Robbe MMQ, van Nijnatten TJA et al (2023) Comparing the diagnostic performance of contrast-enhanced mammography and breast MRI: a systematic review and Meta-Analysis. J Cancer 14:174\u2013182. https:\/\/doi.org\/10.7150\/jca.79747","journal-title":"J Cancer"},{"key":"10574_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/1754-9485.12296","volume":"59","author":"MM Hobbs","year":"2015","unstructured":"Hobbs MM, Taylor DB, Buzynski S, Peake RE (2015) Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): patient preferences and tolerance. J Med Imaging Radiat Oncol 59:300\u2013305. https:\/\/doi.org\/10.1111\/1754-9485.12296","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10574_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clinimag.2016.12.011","volume":"42","author":"J Phillips","year":"2017","unstructured":"Phillips J, Miller MM, Mehta TS et al (2017) Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes. Clin Imaging 42:193\u2013197. https:\/\/doi.org\/10.1016\/j.clinimag.2016.12.011","journal-title":"Clin Imaging"},{"key":"10574_CR10","doi-asserted-by":"publisher","first-page":"W231","DOI":"10.2214\/AJR.16.17239","volume":"208","author":"BK Patel","year":"2017","unstructured":"Patel BK, Gray RJ, Pockaj BA (2017) Potential cost savings of contrast-enhanced digital mammography. AJR Am J Roentgenol 208:W231\u2013W237. https:\/\/doi.org\/10.2214\/AJR.16.17239","journal-title":"AJR Am J Roentgenol"},{"key":"10574_CR11","doi-asserted-by":"publisher","first-page":"S229","DOI":"10.1016\/j.acra.2021.03.003","volume":"29","author":"D Son","year":"2022","unstructured":"Son D, Phillips J, Mehta TS, Mehta R, Brook A, Dialani VM (2022) Patient preferences regarding use of contrast-enhanced imaging for breast cancer screening. Acad Radiol 29:S229\u2013S238. https:\/\/doi.org\/10.1016\/j.acra.2021.03.003","journal-title":"Acad Radiol"},{"key":"10574_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.crad.2023.01.009","volume":"78","author":"SL Savaridas","year":"2023","unstructured":"Savaridas SL, Jin H (2023) Costing analysis to introduce a contrast-enhanced mammography service to replace an existing breast MRI service for local staging of breast cancer. Clin Radiol 78:340\u2013346. https:\/\/doi.org\/10.1016\/j.crad.2023.01.009","journal-title":"Clin Radiol"},{"key":"10574_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2214\/AJR.23.29337","volume":"221","author":"MBI Lobbes","year":"2023","unstructured":"Lobbes MBI, Essers BAB (2023) Cost-effectiveness of breast cancer staging modalities: point\u2014contrast-enhanced mammography as an alternative to breast MRI for preoperative staging in patients with breast cancer. AJR Am J Roentgenol 221:434\u2013435. https:\/\/doi.org\/10.2214\/AJR.23.29337","journal-title":"AJR Am J Roentgenol"},{"key":"10574_CR14","unstructured":"European Commission Initiative on Breast Cancer (2022) Planning surgical treatment: Contrast-enhanced mammography. https:\/\/healthcare-quality.jrc.ec.europa.eu\/en\/ecibc\/european-breast-cancer-guidelines?usertype=60&topic=164&filter_1=167&updatef2=0. Accessed 8 Dec 2023"},{"key":"10574_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-023-07034-7","volume":"202","author":"M Kaiyin","year":"2023","unstructured":"Kaiyin M, Lingling T, Leilei T, Wenjia L, Bin J (2023) Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis. Breast Cancer Res Treat 202:1\u20139. https:\/\/doi.org\/10.1007\/s10549-023-07034-7","journal-title":"Breast Cancer Res Treat"},{"key":"10574_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2214\/AJR.22.28567","volume":"221","author":"TJA van Nijnatten","year":"2023","unstructured":"van Nijnatten TJA, Lobbes MBI, Cozzi A, Patel BK, Zuley ML, Jochelson MS (2023) Barriers to implementation of contrast-enhanced mammography in clinical practice: AJR expert panel narrative review. AJR Am J Roentgenol 221:3\u20136. https:\/\/doi.org\/10.2214\/AJR.22.28567","journal-title":"AJR Am J Roentgenol"},{"key":"10574_CR17","unstructured":"Statistics Division of the United Nations Secretariat (2023) Standard country or area codes for statistical use (M49). https:\/\/unstats.un.org\/unsd\/methodology\/m49\/. Accessed 8 Dec 2023"},{"key":"10574_CR18","doi-asserted-by":"publisher","first-page":"10969","DOI":"10.1007\/s11229-021-03276-4","volume":"199","author":"M Rubin","year":"2021","unstructured":"Rubin M (2021) When to adjust alpha during multiple testing: a consideration of disjunction, conjunction, and individual testing. Synthese 199:10969\u201311000. https:\/\/doi.org\/10.1007\/s11229-021-03276-4","journal-title":"Synthese"},{"key":"10574_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-070113","volume":"377","author":"K Luijken","year":"2022","unstructured":"Luijken K, Dekkers OM, Rosendaal FR, Groenwold RHH (2022) Exploratory analyses in aetiologic research and considerations for assessment of credibility: mini-review of literature. BMJ 377:e070113. https:\/\/doi.org\/10.1136\/bmj-2021-070113","journal-title":"BMJ"},{"key":"10574_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/RLI.0000000000000068","volume":"49","author":"CRLPN Jeukens","year":"2014","unstructured":"Jeukens CRLPN, Lalji UC, Meijer E et al (2014) Radiation exposure of contrast-enhanced spectral mammography compared with full-field digital mammography. Invest Radiol 49:659\u2013665. https:\/\/doi.org\/10.1097\/RLI.0000000000000068","journal-title":"Invest Radiol"},{"key":"10574_CR21","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.acra.2021.12.022","volume":"29","author":"G Bicchierai","year":"2022","unstructured":"Bicchierai G, Busoni S, Tortoli P et al (2022) Single center evaluation of comparative breast radiation dose of contrast enhanced digital mammography (CEDM), digital mammography (DM) and digital breast tomosynthesis (DBT). Acad Radiol 29:1342\u20131349. https:\/\/doi.org\/10.1016\/j.acra.2021.12.022","journal-title":"Acad Radiol"},{"key":"10574_CR22","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/cancers14071774","volume":"14","author":"G Gennaro","year":"2022","unstructured":"Gennaro G, Cozzi A, Schiaffino S, Sardanelli F, Caumo F (2022) Radiation dose of contrast-enhanced mammography: a two-center prospective comparison. Cancers (Basel) 14:1774. https:\/\/doi.org\/10.3390\/cancers14071774","journal-title":"Cancers (Basel)"},{"key":"10574_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00330-010-1944-y","volume":"21","author":"C Dromain","year":"2011","unstructured":"Dromain C, Thibault F, Muller S et al (2011) Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur Radiol 21:565\u2013574. https:\/\/doi.org\/10.1007\/s00330-010-1944-y","journal-title":"Eur Radiol"},{"key":"10574_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1148\/radiol.12121084","volume":"266","author":"MS Jochelson","year":"2013","unstructured":"Jochelson MS, Dershaw DD, Sung JS et al (2013) Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 266:743\u2013751. https:\/\/doi.org\/10.1148\/radiol.12121084","journal-title":"Radiology"},{"key":"10574_CR25","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1007\/s00330-014-3154-5","volume":"24","author":"MBI Lobbes","year":"2014","unstructured":"Lobbes MBI, Lalji U, Houwers J et al (2014) Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme. Eur Radiol 24:1668\u20131676. https:\/\/doi.org\/10.1007\/s00330-014-3154-5","journal-title":"Eur Radiol"},{"key":"10574_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13244-019-0756-0","volume":"10","author":"M Zanardo","year":"2019","unstructured":"Zanardo M, Cozzi A, Trimboli RM et al (2019) Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review. Insights Imaging 10:76. https:\/\/doi.org\/10.1186\/s13244-019-0756-0","journal-title":"Insights Imaging"},{"key":"10574_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jmri.26762","volume":"51","author":"GJ Liao","year":"2020","unstructured":"Liao GJ, Henze Bancroft LC, Strigel RM et al (2020) Background parenchymal enhancement on breast MRI: a comprehensive review. J Magn Reson Imaging 51:43\u201361. https:\/\/doi.org\/10.1002\/jmri.26762","journal-title":"J Magn Reson Imaging"},{"key":"10574_CR28","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1007\/s00330-022-09238-9","volume":"33","author":"D Wessling","year":"2023","unstructured":"Wessling D, M\u00e4nnlin S, Schwarz R et al (2023) Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems? Eur Radiol 33:2945\u20132953. https:\/\/doi.org\/10.1007\/s00330-022-09238-9","journal-title":"Eur Radiol"},{"key":"10574_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1148\/radiol.2016160284","volume":"282","author":"J Sogani","year":"2017","unstructured":"Sogani J, Morris EA, Kaplan JB et al (2017) Comparison of background parenchymal enhancement at contrast-enhanced spectral mammography and breast MR imaging. Radiology 282:63\u201373. https:\/\/doi.org\/10.1148\/radiol.2016160284","journal-title":"Radiology"},{"key":"10574_CR30","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1038\/s41598-020-65526-8","volume":"10","author":"S Zhao","year":"2020","unstructured":"Zhao S, Zhang X, Zhong H et al (2020) Background parenchymal enhancement on contrast-enhanced spectral mammography: influence of age, breast density, menstruation status, and menstrual cycle timing. Sci Rep 10:8608. https:\/\/doi.org\/10.1038\/s41598-020-65526-8","journal-title":"Sci Rep"},{"key":"10574_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12282-022-01345-1","volume":"29","author":"S Yuen","year":"2022","unstructured":"Yuen S, Monzawa S, Gose A et al (2022) Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI. Breast Cancer 29:677\u2013687. https:\/\/doi.org\/10.1007\/s12282-022-01345-1","journal-title":"Breast Cancer"},{"key":"10574_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5603\/GP.a2020.0169","volume":"92","author":"E Luczynska","year":"2021","unstructured":"Luczynska E, Pawlak M, Piegza T et al (2021) Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging. Ginekol Pol 92:92\u201397. https:\/\/doi.org\/10.5603\/GP.a2020.0169","journal-title":"Ginekol Pol"},{"key":"10574_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2214\/AJR.22.28769","volume":"221","author":"S Wang","year":"2023","unstructured":"Wang S, Sun Y, You C et al (2023) Association of clinical factors and degree of early background parenchymal enhancement on contrast-enhanced mammography. AJR Am J Roentgenol 221:45\u201355. https:\/\/doi.org\/10.2214\/AJR.22.28769","journal-title":"AJR Am J Roentgenol"},{"key":"10574_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2214\/AJR.19.22353","volume":"216","author":"Z Karimi","year":"2021","unstructured":"Karimi Z, Phillips J, Slanetz P et al (2021) Factors associated with background parenchymal enhancement on contrast-enhanced mammography. AJR Am J Roentgenol 216:340\u2013348. https:\/\/doi.org\/10.2214\/AJR.19.22353","journal-title":"AJR Am J Roentgenol"},{"key":"10574_CR35","first-page":"1","volume-title":"ACRs BI-RADS\u00ae Atlas","author":"CH Lee","year":"2022","unstructured":"Lee CH, Phillips J, Sung JS, Lewin JM, Newell MS (2022) ACR BI-RADS\u00ae Contrast Enhanced Mammography (CEM). In: ACRs BI-RADS\u00ae Atlas. Breast Imaging Reporting and Data System, American College of Radiology, pp 1\u201364"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10574-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10574-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10574-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T07:07:49Z","timestamp":1721200069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10574-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["10574"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10574-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Dr. Simone Schiaffino, MD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies:  Simone Schiaffino declares to have received travel support from Bracco Imaging, to be a member of the speakers\u2019 bureau for GE Healthcare, and to be a product advisor for Arterys Inc.  Katja Pinker declares being part of speakers bureaus for the European Society of Breast Imaging (active), Bayer (active), Siemens Healthineers (ended), DKD 2019 (ended), and Olea Medical (ended); consulting for Genentech, Merantix Healthcare, and AURA Health Technologies.  All remaining authors declare no competing interest.Paola Clauser, Ritse M. Mann, and Katja Pinker are members of the European Radiology Editorial Board. They have not taken part in the review or selection process of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this survey.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No Institutional Review Board approval was required for this survey.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None of the study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 prospective\u2022 observational\u2022 multicenter study","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}